Appili gets $2.15M in funding to develop superbug fighter



As per the report of  Peter Moreira from chronical herald,
Halifax-based Appili Therapeutics Inc., whose ultimate goal is to produce a drug that treats superbugs, has closed a $2.15-million equity funding round to help fund clinical trials for its first product.
It is very encouraging to see that there are so many people around the globe who are serious about resolving the superbugs crisis and helping the world to come up with a solution.


Please read the full article below.

http://thechronicleherald.ca/business/1426459-entrevestor-appili-gets-2.15m-in-funding-to-develop-superbug-fighter

No comments

Powered by Blogger.